Solventum Corp Files 8-K

TL;DR

Solventum Corp (formerly 3M Health Care) filed its 8-K on 9/8/25. All systems go.

AI Summary

Solventum Corporation, formerly 3M Health Care Co, filed an 8-K on September 8, 2025. The filing indicates the company is incorporated in Delaware and has its principal executive offices at 3M Center, Building 275-6W, East, Maplewood, Minnesota. The filing is related to 'Other Events' and 'Financial Statements and Exhibits'.

Why It Matters

This filing provides official corporate information for Solventum Corporation, a newly independent entity, which is crucial for investors and stakeholders to track its regulatory compliance and corporate structure.

Risk Assessment

Risk Level: low — This is a routine corporate filing providing basic information and does not indicate any immediate financial or operational risks.

Key Numbers

• 001-41968 — SEC File Number (Identifies the company's filing history with the SEC.)
• 92-2008841 — IRS Employer Identification No. (Unique tax identification number for the company.)

Key Players & Entities

• Solventum Corporation (company) — Registrant
• 3M Health Care Co (company) — Former Name
• 3M Company (company) — Associated Company (address)
• September 8, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• Maplewood, Minnesota (location) — Principal Executive Offices

FAQ

Filing Documents

• solv-20250908.htm (8-K) — 27KB
• tenderofferearlytenderresu.htm (EX-99.1) — 49KB
• tenderofferpricing-ex992pr.htm (EX-99.2) — 39KB
• image_0.jpg (GRAPHIC) — 7KB
• image_0a.jpg (GRAPHIC) — 7KB
• 0001964738-25-000084.txt ( ) — 266KB
• solv-20250908.xsd (EX-101.SCH) — 2KB
• solv-20250908_lab.xml (EX-101.LAB) — 22KB
• solv-20250908_pre.xml (EX-101.PRE) — 13KB
• solv-20250908_htm.xml (XML) — 3KB

01. Other Events

Item 8.01. Other Events. Results and Upsizing of Note Tender Offers On September 8, 2025, Solventum Corporation (the "Company") issued a press release announcing the results as of the early participation date and upsizing of its previously announced cash tender offers to purchase certain of its outstanding debt securities (the "Tender Offers"). A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 8.01 by reference. Pricing of Note Tender Offers On September 8, 2025, the Company issued a press release announcing the pricing terms of the Tender Offers. A copy of the press release is attached hereto as Exhibit 99.2 and is incorporated into this Item 8.01 by reference. The information contained in this Current Report on Form 8-K does not constitute an offer to sell, a solicitation to buy, or an offer to purchase any securities. The Tender Offers are being made only pursuant to the Offer to Purchase dated August 22, 2025, as amended by the Company's press release dated September 8, 2025 announcing the results and upsizing of the Tender Offers. The Tender Offers are being made only in such jurisdictions as is permitted under applicable law.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release announcing the results as of the early participation date and upsizing of the Tender Offers, dated September 8, 2025. 99.2 Press release announcing the pricing terms of the Tender Offers, dated September 8, 2025. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SOLVENTUM CORPORATION By: /s/ Wayde McMillan Wayde McMillan Executive Vice President and Chief Financial Officer Dated: September 8, 2025

View Full Filing

View this 8-K filing on SEC EDGAR